Meritxell Carrió

988 total citations
21 papers, 720 citations indexed

About

Meritxell Carrió is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Meritxell Carrió has authored 21 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Meritxell Carrió's work include Neurofibromatosis and Schwannoma Cases (13 papers), Sarcoma Diagnosis and Treatment (7 papers) and Neuroblastoma Research and Treatments (6 papers). Meritxell Carrió is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (13 papers), Sarcoma Diagnosis and Treatment (7 papers) and Neuroblastoma Research and Treatments (6 papers). Meritxell Carrió collaborates with scholars based in Spain, United States and Palestinian Territory. Meritxell Carrió's co-authors include Cristina Fillat, Anna Cascante, Bruno Sangro, Nancy Boudreau, Gemma Arderiu, Connie A. Myers, Mercé Martí, Juan Carlos Izpisúa Belmonte, Leopoldo Laricchia‐Robbio and Cristina Gontan and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Meritxell Carrió

19 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meritxell Carrió Spain 12 443 230 134 115 82 21 720
Silvana Libertini United Kingdom 19 690 1.6× 268 1.2× 472 3.5× 81 0.7× 92 1.1× 31 1.1k
David Foulad United States 13 414 0.9× 213 0.9× 481 3.6× 29 0.3× 80 1.0× 17 1.0k
Lingtao Wu United States 19 716 1.6× 202 0.9× 333 2.5× 31 0.3× 91 1.1× 34 1000
Rebecca D. Dodd United States 18 472 1.1× 78 0.3× 194 1.4× 162 1.4× 169 2.1× 40 897
Shusuke Moriuchi Japan 16 320 0.7× 318 1.4× 126 0.9× 124 1.1× 27 0.3× 35 670
Yasuyoshi Miyao Japan 16 319 0.7× 244 1.1× 148 1.1× 78 0.7× 32 0.4× 49 639
Namitha Manoj United States 3 630 1.4× 291 1.3× 160 1.2× 29 0.3× 40 0.5× 5 842
Akihito Inagaki United States 11 287 0.6× 164 0.7× 336 2.5× 26 0.2× 118 1.4× 18 677
Ryosuke Uchibori Japan 17 452 1.0× 291 1.3× 288 2.1× 17 0.1× 90 1.1× 27 915
Joji Ishida Japan 14 229 0.5× 55 0.2× 81 0.6× 83 0.7× 76 0.9× 49 551

Countries citing papers authored by Meritxell Carrió

Since Specialization
Citations

This map shows the geographic impact of Meritxell Carrió's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meritxell Carrió with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meritxell Carrió more than expected).

Fields of papers citing papers by Meritxell Carrió

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meritxell Carrió. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meritxell Carrió. The network helps show where Meritxell Carrió may publish in the future.

Co-authorship network of co-authors of Meritxell Carrió

This figure shows the co-authorship network connecting the top 25 collaborators of Meritxell Carrió. A scholar is included among the top collaborators of Meritxell Carrió based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meritxell Carrió. Meritxell Carrió is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Ren-Yuan, Jianan Liu, Yuqing Lu, et al.. (2025). Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors. Nature Communications. 16(1). 8594–8594.
2.
Carrió, Meritxell, Bernat Gel, Alberto Villanueva, et al.. (2025). New models for MPNST: establishment and comprehensive characterization of two tumor cell lines. Cancer Cell International. 25(1). 268–268.
3.
Fernández‐Rodríguez, Juana, Ignacio Blanco, Claudia Valverde, et al.. (2024). Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models. Clinical Cancer Research. 31(5). 907–920. 3 indexed citations
4.
Blanco, Ignacio, Elisabeth Castellanos, Conxi Lázaro, et al.. (2024). Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas. JCI Insight. 9(3). 4 indexed citations
5.
Fernández‐Rodríguez, Juana, Alberto Villanueva, Conxi Lázaro, et al.. (2023). Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo uses. STAR Protocols. 4(2). 102198–102198. 1 indexed citations
6.
Fernández‐Rodríguez, Juana, Cleofé Romagosa, Anna Estival, et al.. (2023). Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities. Molecular Oncology. 18(4). 895–917. 2 indexed citations
7.
Fernández‐Rodríguez, Juana, Yvonne Richaud‐Patín, Ernest Terribas, et al.. (2022). Modeling iPSC-derived human neurofibroma-like tumors in mice uncovers the heterogeneity of Schwann cells within plexiform neurofibromas. Cell Reports. 38(7). 110385–110385. 24 indexed citations
8.
Fernández‐Rodríguez, Juana, Ernest Terribas, Cleofé Romagosa, et al.. (2021). Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiation. Human Genetics. 140(8). 1241–1252. 12 indexed citations
9.
Gel, Bernat, Ernest Terribas, Gabrijela Dumbović, et al.. (2021). Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation. Scientific Reports. 11(1). 3661–3661. 6 indexed citations
10.
Carrió, Meritxell, et al.. (2020). Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells. Stem Cell Research. 49. 102068–102068. 7 indexed citations
11.
Carrió, Meritxell, Yvonne Richaud‐Patín, Bernat Gel, et al.. (2019). Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas. Stem Cell Reports. 12(2). 411–426. 31 indexed citations
12.
Carrió, Meritxell, Bernat Gel, Ernest Terribas, et al.. (2018). Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings. Human Mutation. 39(8). 1112–1125. 39 indexed citations
13.
Castellanos, Elisabeth, Cristina Carrato, Meritxell Carrió, et al.. (2018). Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood. JAMA Dermatology. 154(3). 341–341. 11 indexed citations
14.
Martí, Mercé, Cristina Gontan, Meritxell Carrió, et al.. (2013). Characterization of pluripotent stem cells. Nature Protocols. 8(2). 223–253. 119 indexed citations
15.
Pérez‐Torras, Sandra, Meritxell Carrió, Anna Cascante, et al.. (2011). Connexin-26 Is a Key Factor Mediating Gemcitabine Bystander Effect. Molecular Cancer Therapeutics. 10(3). 505–517. 30 indexed citations
16.
Arderiu, Gemma, Ileana Cuevas, Amy Chen, et al.. (2007). HoxA5 Stabilizes Adherens Junctions Via Increased Akt1. Cell Adhesion & Migration. 1(4). 185–195. 45 indexed citations
17.
Carrió, Meritxell, Gemma Arderiu, Connie A. Myers, & Nancy Boudreau. (2005). Homeobox D10 Induces Phenotypic Reversion of Breast Tumor Cells in a Three-Dimensional Culture Model. Cancer Research. 65(16). 7177–7185. 94 indexed citations
18.
Fillat, Cristina, Meritxell Carrió, Anna Cascante, & Bruno Sangro. (2003). Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application. Current Gene Therapy. 3(1). 13–26. 231 indexed citations
19.
Carrió, Meritxell, Joana Visa, Anna Cascante, Xavier Estivill, & Cristina Fillat. (2002). Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV system. The Journal of Gene Medicine. 4(2). 141–149. 15 indexed citations
20.
Mercadé, Elena, Manel Cascalló, Meritxell Carrió, et al.. (2001). Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer.. Annals of Oncology. 12(3). 379–388. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvana Libertini Breakdown of academic impact, for papers by David Foulad Breakdown of academic impact, for papers by Lingtao Wu Breakdown of academic impact, for papers by Rebecca D. Dodd Breakdown of academic impact, for papers by Shusuke Moriuchi Breakdown of academic impact, for papers by Yasuyoshi Miyao Breakdown of academic impact, for papers by Namitha Manoj Breakdown of academic impact, for papers by Akihito Inagaki Breakdown of academic impact, for papers by Ryosuke Uchibori Breakdown of academic impact, for papers by Joji Ishida
Rankless by CCL
2026